Thu, Oct 23, 2014, 10:31 AM EDT - U.S. Markets close in 5 hrs 29 mins

Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • hahamov.david@gmail.com hahamov.david Sep 9, 2013 3:46 PM Flag

    is there a chance thet teva will purchase plx?

    i read that Pfizer is interested in the company due to an cooperation agreement they have, but I believe Teva has more interest in the companies pipeline.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Ask why TEVA CEO Frost and his top Associate Hsaio bailed out some time ago. I don't know the answer I just pose the question.

    • TEVA and any generics maker would be interested.

      Roche/Genentech, Amgen, Pfizer, any company that does biotech drugs would be interested, not so much for making larger profits, but for protecting their own profit margins. If this technology spreads to other countries, they would suffer large profit losses.

      Brazil is making an investment into the technology because they would rather be able to make the drug at 10% of current retail cost. Shire got approved for their Gaucher drug and they're reducing the price only by 15%. They can't/won't sell it cheaper because it's still expensive to manufacture with Chinese Hamster Ovaries. Brazil knows they can't get cheaper generics when it comes to biotech drugs... unless they own the technology themselves.

      Cipla, the Indian generic drug company, who's objective is to bring down drug prices, recently announced that they would make Enbrel for 30% less. They totally destroyed the competition for AIDS drugs by charging $100 per year for AIDS drugs that used to cost $12,000 per year. Imagine if they could manufacture Enbrelfor 90% less.

      Japan, Canada, United Kingdom, France, Germany, Sweden, Norway, Iceland, Denmark, Finland, Netherlands, Switzerland, New Zealand, Italy, Portugal, Greece, Spain, South Korea, Taiwan, Austria,
      Belgium all have socialized medicine/universal healthcare. United States might soon. If Protalix management were smart, they'd ask for an audience in front of each of these countries Health Ministries, or have the Brazilians take this to the World Health Organization itself for discussion.

 
PLX
2.35+0.05(+2.17%)10:23 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.